Home LiteratureArticle Details
PMID: 11095746 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

MHC I-dependent antigen presentation is inhibited by poliovirus protein 3A.

Deitz SB, Dodd DA, Cooper S, Parham P, Kirkegaard K

Abstract

The effects of poliovirus 3A protein expression and poliovirus infection on the presentation of hepatitis C virus antigens in cultured chimpanzee cells were examined. Expression of poliovirus 3A protein inhibits protein secretion when expressed in isolation and was sufficient to protect chimpanzee cells from lysis by hepatitis C virus-specific cytotoxic T cells in standard (51)Cr-release assays. Poliovirus infection also inhibited antigen presentation, as determined by decreased cytotoxic T cell activation. A mutation in 3A that abrogates the inhibition of protein secretion also abolished the effects of poliovirus on antigen presentation. These results demonstrate that the inhibition of secretion observed in poliovirus-infected cells substantially reduces the presentation of new antigens on the cell surface. These observations may reflect a general mechanism by which nonenveloped viruses such as poliovirus and other viruses that do not require a functional protein secretory apparatus can evade detection by the cellular immune response.

MeSH Terms
Animals Cell Line Histocompatibility Antigens Class I/biosynthesis,immunology Pan troglodytes T-Lymphocytes, Cytotoxic/immunology Viral Core Proteins/physiology
Chemicals
3A protein, Poliovirus Histocompatibility Antigens Class I Viral Core Proteins
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Deitz S B
Departments of Microbiology and Immunology, and Structural Biology, Stanford University, School of Medicine, Stanford, CA 94305, USA.
Dodd D A
Cooper S
Parham P
Kirkegaard K
References (36)
36 references, click to expand
  1. Poliovirus-specific major histocompatibility complex class I-restricted cytolytic T-cell epitopes in mice localize to neutralizing antigenic regions.
    J Virol. 1992 Oct;66(10):5967-74 PMID: 1382144
  2. ELECTRON MICROSCOPIC STUDY OF THE FORMATION OF POLIOVIRUS.
    Virology. 1965 Jul;26:379-89 PMID: 14319710
  3. Membrane rearrangement and vesicle induction by recombinant poliovirus 2C and 2BC in human cells.
    Virology. 1994 Jul;202(1):129-45 PMID: 8009827
  4. Induction of membrane proliferation by poliovirus proteins 2C and 2BC.
    Biochem Biophys Res Commun. 1995 Jan 5;206(1):64-76 PMID: 7818552
  5. Inhibition of cellular protein secretion by poliovirus proteins 2B and 3A.
    EMBO J. 1995 Mar 1;14(5):894-907 PMID: 7889939
  6. Poliovirus-specific CD4+ Th1 clones with both cytotoxic and helper activity mediate protective humoral immunity against a lethal poliovirus infection in transgenic mice expressing the human poliovirus receptor.
    J Exp Med. 1995 Apr 1;181(4):1285-92 PMID: 7699320
  7. Selection of recombinant vaccinia viruses on the basis of plaque formation.
    Gene. 1995 Jun 9;158(2):157-62 PMID: 7607536
  8. FACS-optimized mutants of the green fluorescent protein (GFP).
    Gene. 1996;173(1 Spec No):33-8 PMID: 8707053
  9. Cellular origin and ultrastructure of membranes induced during poliovirus infection.
    J Virol. 1996 Oct;70(10):6576-88 PMID: 8794292
  10. The functional half-life of H-2Kd-restricted T cell epitopes on living cells.
    Eur J Immunol. 1996 Sep;26(9):1993-9 PMID: 8814236
  11. Rhinovirus inhibits antigen-specific T cell proliferation through an intercellular adhesion molecule-1-dependent mechanism.
    J Infect Dis. 1996 Dec;174(6):1143-50 PMID: 8940202
  12. How viruses escape from cytotoxic T lymphocytes: molecular parameters and players.
    Virology. 1997 Aug 4;234(2):179-85 PMID: 9268148
  13. Analysis of a successful immune response against hepatitis C virus.
    Immunity. 1999 Apr;10(4):439-49 PMID: 10229187
  14. Biotinylation of class I MHC molecules abrogates recognition by W6/32 antibody.
    Tissue Antigens. 1999 Jun;53(6):576-9 PMID: 10395109
  15. Human pathogen subversion of antigen presentation.
    Immunol Rev. 1999 Apr;168:199-215 PMID: 10399076
  16. Mucosal immunization of cynomolgus macaques with two serotypes of live poliovirus vectors expressing simian immunodeficiency virus antigens: stimulation of humoral, mucosal, and cellular immunity.
    J Virol. 1999 Nov;73(11):9485-95 PMID: 10516057
  17. Remodeling the endoplasmic reticulum by poliovirus infection and by individual viral proteins: an autophagy-like origin for virus-induced vesicles.
    J Virol. 2000 Oct;74(19):8953-65 PMID: 10982339
  18. Characterization of a monoclonal anti-beta 2-microglobulin antibody and its use in the genetic and biochemical analysis of major histocompatibility antigens.
    Eur J Immunol. 1979 Jul;9(7):536-45 PMID: 91522
  19. Modification of membrane permeability in poliovirus-infected HeLa cells: effect of guanidine.
    J Gen Virol. 1983 Apr;64 (Pt 4):787-93 PMID: 6300301
  20. Poliovirus mutant that contains a cold-sensitive defect in viral RNA synthesis.
    J Virol. 1988 Aug;62(8):2922-8 PMID: 2839711
  21. Cellular receptor for poliovirus: molecular cloning, nucleotide sequence, and expression of a new member of the immunoglobulin superfamily.
    Cell. 1989 Mar 10;56(5):855-65 PMID: 2538245
  22. Cytolytic T-lymphocyte response to isolated class I H-2 proteins and influenza peptides.
    Nature. 1989 Jul 13;340(6229):157-9 PMID: 2786997
  23. Lack of detectable endocytosis of B lymphocyte MHC class II antigens using an antibody-independent technique.
    J Immunol. 1990 Feb 1;144(3):990-7 PMID: 2295824
  24. Transgenic mice expressing a human poliovirus receptor: a new model for poliomyelitis.
    Cell. 1990 Oct 19;63(2):353-62 PMID: 2170026
  25. Transgenic mice susceptible to poliovirus.
    Proc Natl Acad Sci U S A. 1991 Feb 1;88(3):951-5 PMID: 1846972
  26. BLT esterase activity as an alternative to chromium release in cytotoxic T cell assays.
    J Immunol Methods. 1991 Dec 15;145(1-2):43-53 PMID: 1722495
  27. Structural and functional characterization of the poliovirus replication complex.
    J Virol. 1992 May;66(5):2740-7 PMID: 1313898
  28. Poliovirus 2C protein determinants of membrane binding and rearrangements in mammalian cells.
    J Virol. 1997 Dec;71(12):8962-72 PMID: 9371552
  29. Inhibition of endoplasmic reticulum-to-Golgi traffic by poliovirus protein 3A: genetic and ultrastructural analysis.
    J Virol. 1997 Dec;71(12):9054-64 PMID: 9371562
  30. Viral strategies of immune evasion.
    Science. 1998 Apr 10;280(5361):248-53 PMID: 9535648
  31. Poliovirus vaccine vectors elicit antigen-specific cytotoxic T cells and protect mice against lethal challenge with malignant melanoma cells expressing a model antigen.
    Proc Natl Acad Sci U S A. 1998 Jul 7;95(14):8216-21 PMID: 9653167
  32. The clathrin endocytic pathway in viral infection.
    EMBO J. 1998 Aug 17;17(16):4585-93 PMID: 9707418
  33. Immunologic complexity in neurons.
    Neuron. 1998 Nov;21(5):947-50 PMID: 9856451
  34. A Theiler's virus alternatively initiated protein inhibits the generation of H-2K-restricted virus-specific cytotoxicity.
    J Immunol. 1999 Jan 1;162(1):17-24 PMID: 9886365
  35. Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen.
    Nature. 1999 Mar 4;398(6722):77-80 PMID: 10078533
  36. Hepatitis C virus-specific CTL responses in the liver of chimpanzees with acute and chronic hepatitis C.
    J Immunol. 1993 Oct 15;151(8):4189-99 PMID: 7691940
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
2000-12-05
Pages
13790-5
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC17654
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]